Vaccine News and Research

Latest Vaccine News and Research

National U.S trial confirms effectiveness of mRNA COVID-19 vaccines

In a recent study, published in the Annals of Internal Medicine, scientists conducted a target trial emulation study and documented that among the elderly in the U.S. (with significant comorbidities), the efficacy of messenger RNA (mRNA) vaccines was much lower in terms of preventing infection, than previously reported. However, the effectiveness against death was found to be high.

21 Dec 2021

How the SARS-CoV-2 Omicron variant spike protein is changing

The study assesses the degree to which the D614G mutation in the SARS-CoV-2 RBD allows access of spike protein trimers to LA-binding-like conformations.

21 Dec 2021

Comparison of point-of-care SARS-CoV-2 diagnostic kits

A multinational group of scientists investigates the performance characteristics of several point-of-care diagnostic kits for SARS-CoV-2.

21 Dec 2021

UK research investigates relationship between COVID-19 vaccination and Guillain-Barré syndrome

Researchers investigate the possible relationship between COVID-19 vaccination and the incidences of Guillain-Barre syndrome.

21 Dec 2021

Booster doses offer broader protection in SARS-CoV-2 infected and vaccinated individuals

Researchers determined IgG titers of vaccinated healthcare workers 11 months following primary COVID-19 vaccination.

21 Dec 2021

Stabilizing the long-term endemic behavior of COVID-19

Researchers used a classic age and contact structured model to explore the several reopening and vaccination coverage scenarios regarding the COVID-19 pandemic.

21 Dec 2021

Understanding SARS-CoV-2-induced systemic amyloidosis

A new study proposed that inflammation combined with aggregates of amyloidogenic peptides of SARS-CoV-2 S proteins might induce systemic amyloidosis.

21 Dec 2021

COVID-19 vaccine protection declines after three months of receiving two doses

The protection offered by the Oxford-Astra Zeneca Covid-19 vaccine declines after three months of receiving two doses, a study says.

21 Dec 2021

Identifying a recurring pattern in broadly neutralizing antibodies that can target an epitope on SARS-CoV-2

Interesting research decrypts a recurring sequence in antibodies against severe acute respiratory syndrome 2 (SARS-CoV-2) and identifies it to be a board neutralizing antibody that targets a conserved epitope on the SARS-CoV-2 receptor-binding domain (RBD) of the spike protein.

21 Dec 2021

Risk of hospitalization for infants and children with COVID-19 below 1%

Children are a low-risk group for COVID-19 following infection with SARS-CoV-2, with less than 2% of European hospitalizations with the disease being in children below the age of 19.

21 Dec 2021

Efficacy of the mRNA-1273 vaccine against emerging COVID-19 variants

A new study emphasized the effectiveness of two doses of mRNA-1273 in preventing infection with SARS-CoV-2 and hospital admission with covid-19 due to variants including delta.

21 Dec 2021

Estimating vaccine efficacy against COVID-like illness from omicron and other COVID-19 variants

A new study combines real-time syndromic surveillance data from daily cross-sectional surveys with a COVID-like illness (CLI) prevalence-based vaccine efficacy estimator to better explain the early onset of the omicron variant.

21 Dec 2021

Study finds scarcity in COVID-19 vaccine supply decreases perceived vaccination priority

Anyone who has taken an economics class probably remembers learning about scarcity. The concept of demand outpacing supply applies to the toilet paper shortage at the onset of the COVID-19 pandemic and helps explain how a spike in home-improvement projects last year contributed to skyrocketing lumber prices.

21 Dec 2021

Study examines the sustainability of interventions on HPV vaccination rates several years after completion

Approximately 45,300 Human papillomavirus (HPV)-related cancers occur in the U.S. every year. HPV vaccination has the potential to prevent up to 80 percent of these cancers. While raising HPV vaccination rates has been a public health priority since 2014, improving these numbers has been slow and uneven.

21 Dec 2021

Researchers create 'UV Curtain' that can sterilize rooms against coronaviruses

Researchers from the Ludwig Maximilian University of Munich have created a new system to protect areas from the virus, using a light-emitting diode (LED)-based ultraviolet C (UV-C) light curtain. Specific wavelengths of UV-C are known to inactivate viruses and bacteria, and this tool could help keep areas sterile.

20 Dec 2021

Booster shots improve CD8+ T cell response to SARS-CoV-2 in animal model

In a new study, published on the bioRxiv* preprint server, scientists showed in a mice model that three doses of the same synthetic peptide vaccine, eliciting an exclusive CD8+ T cell response against one SARS-CoV-2 Spike epitope, protected against lethal SARS-CoV-2 infection, in the absence of neutralizing antibodies. Researchers also showed that the third dose resulted in superior generation of effector-memory T cells in the circulation and tissue-resident memory T (TRM) cells.

20 Dec 2021

New €8 million multiyear contribution agreement signed to support equitable access for health products

On 16 December 2021 the Government of Belgium and WHO signed a new €8 million multiyear contribution agreement for the period 2021-2025, to support increasing global equitable access to health products and health technologies globally.

20 Dec 2021

An Omicron wave predicted for England from December 2021 to April 2022

A study, published on the medRxiv* preprint server, focuses on the interaction between Omicron variants and public health interventions in England that promote immunity.

20 Dec 2021

New Omicron variant may be better at evading vaccine-induced antibodies, research shows

The Omicron variant of SARS-CoV-2 may be significantly better than previous variants at evading vaccine-induced antibodies, according to new research from Cambridge - but preliminary evidence suggests it is less likely to cause severe COVID-19 illness in the lungs.

20 Dec 2021

£316 million funding boost to protect tens of thousands of people from homelessness

Tens of thousands of people will be protected from homelessness as a result of a £316 million funding boost, announced by the Department for Levelling Up, Housing and Communities today (21 December 2021).

20 Dec 2021

Vaccine News and Research

Latest Vaccine News and Research

National U.S trial confirms effectiveness of mRNA COVID-19 vaccines

How the SARS-CoV-2 Omicron variant spike protein is changing

Comparison of point-of-care SARS-CoV-2 diagnostic kits

UK research investigates relationship between COVID-19 vaccination and Guillain-Barré syndrome

Booster doses offer broader protection in SARS-CoV-2 infected and vaccinated individuals

Stabilizing the long-term endemic behavior of COVID-19

Understanding SARS-CoV-2-induced systemic amyloidosis

COVID-19 vaccine protection declines after three months of receiving two doses

Identifying a recurring pattern in broadly neutralizing antibodies that can target an epitope on SARS-CoV-2

Risk of hospitalization for infants and children with COVID-19 below 1%

Efficacy of the mRNA-1273 vaccine against emerging COVID-19 variants

Estimating vaccine efficacy against COVID-like illness from omicron and other COVID-19 variants

Study finds scarcity in COVID-19 vaccine supply decreases perceived vaccination priority

Study examines the sustainability of interventions on HPV vaccination rates several years after completion

Researchers create 'UV Curtain' that can sterilize rooms against coronaviruses

Booster shots improve CD8+ T cell response to SARS-CoV-2 in animal model

New €8 million multiyear contribution agreement signed to support equitable access for health products

An Omicron wave predicted for England from December 2021 to April 2022

New Omicron variant may be better at evading vaccine-induced antibodies, research shows

£316 million funding boost to protect tens of thousands of people from homelessness

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in